The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other ...

These exchange-traded funds won't even need constant monitoring. In fact, you'd be better served in the long run by not ...

Scott Olson / Getty Images The Roundhill GLP-1 & Weight Loss ETF and the Amplify Weight Loss Drug & Treatment ETF were launched in May to tap into the recent popularity of obesity drugs.

senior health care analyst at Global X ETFs. "From there, only an estimated 9.6% of drugs that enter phase 1 clinical testing are expected to reach the market, though biotechnology treatments that ...

Get detailed information about the Huatai-PB Hang Seng Invt Drug (QDII) ETF. View the current 520500 stock price chart, historical data, premarket price, dividend returns and more.

“With the likely upcoming reclassification of cannabis to a Schedule III drug potentially serving as a catalyst for the space, Roundhill is offering this fee waiver for the WEED ETF to make ...

President Donald Trump announced plans to sign an executive order aimed at significantly reducing U.S. prescription drug prices by 30% to 80%. The initiative, known as the "most favored nation" policy ...

The proposal is expected to face strong pushback once again from drug manufacturers (read: A Look at Pharma ETFs After Strong Q1 Earnings). This policy has immediate implications for the ...